https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/blood-disorders

The Latest

NHS hospital

More Than 30 Years Later, the UK Government Opens Inquiry Into Blood Contaminated With HIV and Hepatitis C

On Sept. 24, the first widespread inquiry into how thousands of people in the United Kingdom received contaminated blood in the 1970s and 1980s began with a preliminary hearing and a commemoration event dedicated to the victims.

USA Today Examines HIV/AIDS Among Hemophiliacs, History of Virus in U.S. Blood Supply

USA Today on Wednesday examined HIV/AIDS among hemophiliacs and the history of the virus in the U.S. blood supply. Hemophilia, a condition in which a person's blood does not clot normally, mostly occurs in men, and hemophiliacs need transfusions of c...

Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients

Guidelines for HIV/hepatitis C virus (HCV)-coinfected patients recommend HCV treatment with pegylated interferon-alfa (PEG-IFN) plus ribavirin (RBV). The adverse effects of IFN/RBV, particularly anemia, may be more common among HIV/HCV-coinfected tha...

Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations

In the beginning, there was zidovudine (AZT, Retrovir). As the first antiretroviral drug approved for the treatment of HIV, its benefits during the early years of the epidemic were incalculable. However, zidovudine's use also had at least one downsid...

HIV/AIDS Anemia: Prevalence and Severity of Anemia Increases With Advancing HIV Disease

The current study describes the prevalence of anemia, a common hematologic abnormality that can significantly impact clinical outcomes and quality of life (QOL), in several populations of patients with HIV. Specifically, P.S. Belperio and colleagues ...

Longer Dosing Intervals of Epoetin Alfa Are Effective in Maintaining Hemoglobin Levels in Anemic, HIV-Infected Patients

Introduction Anemia, defined as a reduction below normal in the number of red blood cells or quantity of hemoglobin, has long been recognized as an important clinical problem in HIV disease. It remains the most frequent blood-related complication in...

New Hemophilia Treatment Has Virtually No HIV Transmission Risk

Last week, FDA approved Advate, a hemophilia A treatment containing no human blood components. The drug will be available in pharmacies within two to five weeks. Baxter Healthcare Corp., the drug's developer, has not determined its average wholesale ...

Early Diagnosis and Appropriate Treatment of HIV-Related Anemia Important to Survival of the HIV-Positive

Association of Treatments for Anemia and Survival Among Persons With HIV Infection and Anemia (Poster 1154) Authored by P. Sullivan, S. Buskin Background Anemia in the setting of HIV disease is common, especially among women, African American...

Mild to Moderate Anemia Remains Common in HIV Patients

Anemia Prevalence Among HIV Patients: Antiretroviral Therapy and Other Risk Factors (Poster 1151) Authored by J.P. Nadler, T.S. Wills, C. Somboonwit, A. Vincent, G. Leitz, K. Marino, E. Naik, S. Powers, N. Khan, N. Almyroudis, B. Laartz Introd...

Lawsuit Alleges Companies Sold Contaminated Blood Overseas

Several hemophiliacs have sued health care giant Bayer Corp. and other companies, claiming they knowingly sold HIV- and hepatitis C-contaminated blood products. The suit, filed in a San Francisco federal court, seeks class action status on behalf of ...